Discrepancies between clinical and radiological assessment of complete remission of rectal cancer after neoadjuvant radiochemotherapy

新辅助放化疗后直肠癌完全缓解的临床评估与放射学评估结果存在差异

阅读:1

Abstract

AIM: The watch & wait concept in rectal cancer offers a promising non-operative strategy for patients who achieve a complete response following neoadjuvant radiochemotherapy (nRCT). However, accurately diagnosing clinical complete remission (cCR) based on clinical examinations, endoscopy and imaging remains a major challenge. METHODS: This retrospective study included patients with rectal cancer who received nRCT at the University Hospital Erlangen between May 2022 and July 2024 (radiation: 50.4–54 Gy or 5x5 Gy; chemotherapy: 5-FU and oxaliplatin, partially as part of a total neoadjuvant therapy (TNT) concept). Patients were analyzed based on their clinical, endoscopic, and radiological findings, and classified as having either consistent or discrepant diagnostic results. Particular attention was paid to patients with discrepancies between diagnostic modalities. RESULTS: A total of 78 patients underwent nRCT for rectal cancer during the study period. Six patients were excluded due to a second malignancy, tumor recurrence, or incomplete restaging. 72 patients were included in the final analysis. Of these, 46 patients showed consistent evidence of residual tumor during restaging, leading to surgical resection, with histopathological confirmation of residual tumor in 76% of cases. A clinical and radiological complete remission was observed in 12 of 72 patients (16.7%), four of whom experienced local regrowth. Discrepancies were noted between clinical, endoscopic and radiological findings following nRCT in 14 patients (median age 68 years, range 40–73). Of these patients, 13 had a negative MRI and one had a negative endoscopy, despite differing findings on the other modalities. CONCLUSION: Diagnosing complete remission after nRCT remains challenging within the context of a watch & wait strategy. Our findings suggest that pelvic MRI may overestimate the response to treatment. This is consistent with published data. Discrepancies between clinical, endoscopic, and radiologic assessments should prompt caution and emphasize the need for individualized decision-making before surgery is omitted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。